首页> 外文OA文献 >Effects of the tachykinin NK1 receptor antagonist, RP 67580, on central cardiovascular and behavioural effects of substance P, neurokinin A and neurokinin B.
【2h】

Effects of the tachykinin NK1 receptor antagonist, RP 67580, on central cardiovascular and behavioural effects of substance P, neurokinin A and neurokinin B.

机译:速激肽NK1受体拮抗剂RP 67580对P物质,神经激肽A和神经激肽B的中枢心血管和行为作用的影响。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

1. We have investigated the effects of the non-peptide NK1 tachykinin receptor antagonist, RP 67580, and its inactive enantiomer, RP 68651, on the cardiovascular and behavioural responses to substance P (SP), neurokinin A (NKA) and neurokinin B (NKB) injected intracerebroventricularly (i.c.v.) in conscious rats. 2. The SP and NKA (25 pmol)-induced increases in blood pressure (BP) and heart rate (HR) were of the same magnitude. The cardiovascular responses to both peptides were associated with excessive grooming behaviour and wet dog shakes (WDS). Relative to SP, NKA was weaker in inducing hindquarter grooming (HG), but more effective in eliciting WDS. The cardiovascular response to NKB (50 pmol) comprised an increase in BP and HR, while the behavioural response was weak. 3. RP 67580 (100 pmol), injected 10 or 30 min prior to SP, effectively inhibited the cardiovascular and behavioural responses to the peptide whereas lower doses were ineffective. Pretreatment with 500 pmol of RP 67580, 10 or 30 min prior to SP, reduced the BP response. Of the behavioural manifestations, only face washing was attenuated when the antagonist was injected 10 min before SP. At 2500 pmol, the antagonist exaggerated the BP response to the peptide without affecting the behavioural response. RP 68651 (100 or 2500 pmol) did not modify the central responses to SP. 4. Neither RP 67580 nor RP 68651 (100 pmol), affected the cardiovascular and behavioural responses to NKA or NKB. 5. Our results indicate that RP 67580 is a selective and high affinity antagonist at central NK1 tachykinin receptors in the rat.
机译:1.我们研究了非肽NK1速激肽受体拮抗剂RP 67580及其非活性对映体RP 68651对P(SP),神经激肽A(NKA)和神经激肽B( NKB)脑室内(icv)注射到清醒大鼠中。 2. SP和NKA(25 pmol)引起的血压(BP)和心率(HR)升高幅度相同。对这两种肽的心血管反应均与过度的修饰行为和湿狗摇(WDS)有关。相对于SP,NKA在诱导后肢修饰(HG)方面较弱,但在引发WDS方面更有效。对NKB(50 pmol)的心血管反应包括BP和HR升高,而行为反应较弱。 3.在SP之前10或30分钟注射的RP 67580(100 pmol)可有效抑制对该肽的心血管和行为反应,而较低剂量则无效。在SP之前10或30分钟,用500 pmol RP 67580进行预处理可以降低BP反应。在行为表现中,当在SP之前10分钟注射拮抗剂时,仅有洗脸的感觉减弱。在2500 pmol时,拮抗剂会夸大对肽的BP反应,而不会影响行为反应。 RP 68651(100或2500 pmol)没有改变对SP的中枢反应。 4. RP 67580和RP 68651(100 pmol)均未影响对NKA或NKB的心血管和行为反应。 5.我们的结果表明,RP 67580是大鼠中枢NK1速激肽受体的选择性高亲和性拮抗剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号